LYFE

2ndVote Life Neutral Plus ETF [LYFE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

LYFE Stock Summary

In the News

LYFE Financial details

Company Rating
-
Market Cap
6.69B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.62
Dividend %
1.86%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
28.84-34.38
52W High
-1.22%
52W Low
+19.95%
RSI
-
Rel Volume
-
Avg Volume
-
Volume
270
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0.01%
Price
33.5848
Change
0.01%

LYFE Financial Performance

LYFE Dividend History

LYFE Frequently Asked Questions

What is 2ndVote Life Neutral Plus ETF stock symbol ?

2ndVote Life Neutral Plus ETF is a US stock and trading under the symbol LYFE

What is 2ndVote Life Neutral Plus ETF stock quote today ?

2ndVote Life Neutral Plus ETF stock price is $33.5848 today.

Is 2ndVote Life Neutral Plus ETF stock public?

Yes, 2ndVote Life Neutral Plus ETF is a publicly traded company.

Something similar

Top by Market Cap
EMBASSY.NS
LLY
3V64.DE
VTI
APC.DE
Interesting
CLF
FSZ
APDN
PHAR.L
CGTX
Check Those
TBI
PRK
ACQ.TO
CLRI
CFVIU
Similar Market Cap
603992.SS
002895.SZ
002588.SZ
FAMKX
RGL.NS

Company Profile

  • Market Capitalization 6.69B
  • Headquarters US
  • IPO Date 2020-11-17

The fund is an actively managed ETF. Under normal circumstances, the fund seeks to meet its investment objective by primarily investing its net assets, plus borrowings for investment purposes, if any, in the equity securities of large- and mid- capitalization companies domiciled in the U.S. and/or principally traded in U.S. securities market that meet its pro-life social criteria. It uses a fundamental security analysis and proprietary social scoring system to select the equity securities.